Clover Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Clover şirketinin kazançları yıllık ortalama -24.1% oranında azalırken, Chemicals sektörünün kazançları yıllık 9.1% oranında artan oldu. Gelirler yıllık ortalama 3.6% oranında azalan oldu. Clover şirketinin öz sermaye getirisi 2.3% olup, net marjı 2.4% dir.

Anahtar bilgiler

-24.1%

Kazanç büyüme oranı

-24.3%

EPS büyüme oranı

Chemicals Sektör Büyümesi	14.4%
Gelir büyüme oranı	-3.6%
Özkaynak getirisi	2.3%
Net Marj	2.4%
Son Kazanç Güncellemesi	31 Jul 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Clover nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

CHIA:CLV Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
31 Jul 24	62	2	11	2
30 Apr 24	62	2	11	3
31 Jan 24	63	2	11	3
31 Oct 23	71	4	11	3
31 Jul 23	80	6	12	3
30 Apr 23	83	7	11	2
31 Jan 23	85	9	10	2
31 Oct 22	78	8	9	2
31 Jul 22	71	7	9	2
30 Apr 22	66	6	9	2
31 Jan 22	61	6	9	2
31 Oct 21	61	6	8	2
31 Jul 21	61	6	8	2
30 Apr 21	70	8	8	2
31 Jan 21	80	10	8	3
31 Oct 20	84	11	9	2
31 Jul 20	88	12	9	2
30 Apr 20	84	11	9	2
31 Jan 20	80	10	9	2
31 Oct 19	78	10	9	2
31 Jul 19	77	10	9	2
30 Apr 19	71	9	8	2
31 Jan 19	66	9	8	1
31 Oct 18	65	8	7	1
31 Jul 18	63	8	7	2
30 Apr 18	61	7	6	1
31 Jan 18	59	6	5	1
31 Oct 17	54	5	5	1
31 Jul 17	48	4	5	1
30 Apr 17	45	3	5	1
31 Jan 17	43	2	5	1
31 Oct 16	43	2	5	1
31 Jul 16	43	2	5	1
30 Apr 16	38	1	5	1
31 Jan 16	34	0	5	2
31 Oct 15	32	0	5	2
31 Jul 15	30	0	5	2
30 Apr 15	29	0	4	2
31 Jan 15	28	0	4	2
31 Oct 14	28	1	4	2
31 Jul 14	27	1	5	2
30 Apr 14	33	3	5	2
31 Jan 14	39	5	6	2

Kaliteli Kazançlar: CLV yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: CLV 'nin mevcut net kar marjları (2.4%) geçen yılın (7.8%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: CLV şirketinin kazançları son 5 yılda yılda 24.1% oranında azaldı.

Büyüme Hızlandırma: CLV 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: CLV geçtiğimiz yıl negatif kazanç büyümesine ( -75.6% ) sahipti ve bu da onu Chemicals sektör ortalamasıyla ( 4% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: CLV 'nin Özsermaye Getirisi ( 2.3% ) düşük olarak değerlendiriliyor.

Clover Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings released: EPS: AU$0.009 (vs AU$0.037 in FY 2023)

First half 2024 earnings released: AU$0.004 loss per share (vs AU$0.022 profit in 1H 2023)

Full year 2023 earnings released: EPS: AU$0.037 (vs AU$0.043 in FY 2022)

First half 2023 earnings released: EPS: AU$0.022 (vs AU$0.012 in 1H 2022)

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: EPS AU$0.036 (vs AU$0.075 in FY 2020)

Recent updates

Dividend of AU$0.0075 announced

Full year 2024 earnings released: EPS: AU$0.009 (vs AU$0.037 in FY 2023)

New major risk - Revenue and earnings growth

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Independent Non-Executive Chairman recently bought AU$100k worth of stock

Now 23% undervalued after recent price drop

First half 2024 earnings released: AU$0.004 loss per share (vs AU$0.022 profit in 1H 2023)

Clover Corporation Limited Declares Payment of Final Dividend for the Financial Year 2023

Insufficient new directors

Clover Corporation Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Market cap size

Full year 2023 earnings released: EPS: AU$0.037 (vs AU$0.043 in FY 2022)

Clover Corporation Limited Declares Fully Franked Final Dividend for the Financial Year Ended 31 July 2023, Payable on 20 November 2023

First half 2023 earnings released: EPS: AU$0.022 (vs AU$0.012 in 1H 2022)

Clover Corporation Limited Payment of Final Dividend for the Financial Year 2022

Clover Informs Study Results by the South Australian Health and Medical Research Institute

Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 July 2022, Payable on 22 November 2022

Upcoming dividend of AU$0.01 per share

Clover Corporation Limited, Annual General Meeting, Nov 24, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Now 23% undervalued after recent price drop

Full year 2021 earnings released: EPS AU$0.036 (vs AU$0.075 in FY 2020)

Investor sentiment improved over the past week

CFO & Company Secretary has left the company

Investor sentiment deteriorated over the past week

Clover Corporation Ltd Announces Payment of Interim Dividend for the Half Year Ended January 31, 2021

Investor sentiment improved over the past week

First half 2021 earnings released: EPS AU$0.015 (vs AU$0.028 in 1H 2020)

Clover Corporation Limited Provides Revenue Guidance for the Fiscal Year 2021

Clover Corporation Limited Declares Dividend for the First Half of 2021, Payable on April 29, 2021

New 90-day low: AU$1.45

New 90-day low: AU$1.47

New 90-day low: AU$1.62

CEO, MD & Director recently sold AU$404k worth of stock

Independent Chairman recently bought AU$99k worth of stock

Clover Corporation Limited Announces Board Changes

New 90-day low: AU$2.00

New 90-day low: AU$2.10

Full year earnings released

New 90-day high - AU$2.40

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin